HHS Secretary comments on Supreme Court decision affecting mifepristone approval

Webp raerh9tf8220k7ydaas9a6ubmvlu

HHS Secretary comments on Supreme Court decision affecting mifepristone approval

Xavier Becerra United States Secretary of Health and Human Services | Official Website

U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra issued a statement today in response to the Supreme Court’s unanimous decision in Food and Drug Administration v. Alliance for Hippocratic Medicine.

"Mifepristone has been used safely and effectively for more than two decades since it was first approved by the FDA, one of our nation’s most critical public health agencies. Today, this critical medication remains approved and available," Becerra stated.

Becerra emphasized ongoing concerns regarding women's health, stating, "But let’s be clear: women’s health remains under attack. The overturning of Roe v. Wade paved the way for attacks on reproductive rights and women’s ability to make their own decisions about abortion, birth control, and IVF."

He highlighted the daily impact on women across various states due to these changes in reproductive rights legislation. "Every day, women in states across America are forced to live with the devastating consequences of these attacks on reproductive rights," he said.

Becerra reiterated that healthcare decisions should be made by women in consultation with their doctors rather than politicians. He assured that HHS would continue its efforts to strengthen and expand access to healthcare, protect privacy protections, and preserve individual rights.

"We will continue the fight to restore Roe v. Wade and defend reproductive rights for all Americans," Becerra concluded.